Insider · CIK 0001861067

Eichorn Laura G.

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001861067

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-11	Imago BioSciences, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	+246K sh	$36.00	+$8.87M	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−11.4K sh	—	—	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−101K sh	—	—	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−11.8K sh	—	—	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−4,217 sh	—	—	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−103K sh	—	—	0
2023-01-03	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+23K sh	$2.52	+$57.8K	232,284
2023-01-03	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.4K sh	$4.20	+$52.1K	244,684
2023-01-03	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,769 sh	$22.76	+$40.3K	246,453
2023-01-03	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−23K sh	—	—	0
2023-01-03	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.4K sh	—	—	11,409
2023-01-03	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,769 sh	—	—	101,231
2022-12-27	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,100 sh	$2.52	+$7,812	210,837
2022-12-27	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−3,100 sh	$35.93	−$111K	207,737
2022-12-27	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,100 sh	—	—	22,950
2022-12-15	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+18K sh	$2.10	+$37.8K	225,717
2022-12-15	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,976 sh	$2.19	+$6,517.44	228,693
2022-12-15	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,380 sh	$2.27	+$5,402.6	231,073
2022-12-15	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+73K sh	$2.52	+$184K	304,073
2022-12-15	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+30.4K sh	$1.52	+$46.2K	334,451
2022-12-15	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−127K sh	$35.79	−$4.54M	207,737
2022-12-15	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−18K sh	—	—	11,781
2022-12-15	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,976 sh	—	—	0
2022-12-15	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,380 sh	—	—	0
2022-12-15	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−73K sh	—	—	26,050
2022-12-15	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−30.4K sh	—	—	4,217
2022-11-08	Imago BioSciences, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+103K sh	—	—	103,000
2022-11-02	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+553 sh	$2.52	+$1,393.56	208,290
2022-11-02	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−553 sh	$18.00	−$9,954	207,737
2022-11-02	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−553 sh	—	—	99,050
2022-08-22	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+447 sh	$2.52	+$1,126.44	208,184
2022-08-22	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−447 sh	$18.00	−$8,046	207,737
2022-08-22	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−447 sh	—	—	99,603
2022-08-17	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+373 sh	$2.52	+$939.96	208,110
2022-08-17	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−373 sh	$19.50	−$7,274.06	207,737
2022-08-17	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−373 sh	—	—	100,050
2022-08-16	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+533 sh	$2.52	+$1,343.16	208,270
2022-08-16	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−533 sh	$19.50	−$10.4K	207,737
2022-08-16	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−533 sh	—	—	100,423
2022-07-20	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$2.52	+$2,520	208,737
2022-07-20	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−1,000 sh	$18.00	−$18K	207,737
2022-07-20	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	100,956
2022-02-22	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,000 sh	$2.52	+$20.2K	215,737
2022-02-22	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−7,600 sh	$21.57	−$164K	208,137
2022-02-22	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−400 sh	$22.16	−$8,864	207,737
2022-02-22	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,000 sh	—	—	101,956
2022-02-11	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$1.52	+$6,080	211,737
2022-02-11	Imago BioSciences, Inc.S Sale	Chief Financial Officer	SSale	−4,000 sh	$23.61	−$94.5K	207,737
2022-02-11	Imago BioSciences, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	34,595
2022-02-09	Imago BioSciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$1.52	+$6,080	211,737

Recent filings

Accepted (ET)
Jan 114
Eichorn Laura G.0000899243-23-001601
SEC(opens sec.gov)
Jan 54
Eichorn Laura G.0001567619-23-000460
SEC(opens sec.gov)
Dec 294
Eichorn Laura G.0001567619-22-022097
SEC(opens sec.gov)
Dec 194
Eichorn Laura G.0001567619-22-021788
SEC(opens sec.gov)

Companies

Imago BioSciences, Inc.Chief Financial Officer

Address

C/O IMAGO BIOSCIENCES, INC. 329 OYSTER POINT BLVD, 3RD FLOOR

SOUTH SAN FRANCISCO, CA, 94080